Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review
Article in Multiple Sclerosis and Related Disorders (June 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Multiple Sclerosis and Related Disorders (June 2024)
Article in Saudi Journal of Ophthalmology (March 2024)
Article in ACS Chemical Neuroscience (February 2024)